Incorporating Inflammation Biomarker-Driven Multivariate Predictive Model for Coronary Microcirculatory Dysfunction

Zhuoya Yao1, Bin Ding1, Jun Wang1

  • 1Department of Cardiovascular Disease, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.

Clinical Cardiology
|October 21, 2024
PubMed

Insights

A new predictive model accurately identifies coronary microcirculatory dysfunction (CMD) in acute myocardial infarction (AMI) patients post-percutaneous coronary intervention (PCI), using readily available clinical data to flag high-risk individuals.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Predictive Modeling

Background:

  • Coronary microcirculatory dysfunction (CMD) can lead to adverse outcomes despite successful revascularization in acute myocardial infarction (AMI) patients.
  • Effective management of CMD post-emergency percutaneous coronary intervention (PCI) is crucial for preventing complications.
  • A multimodal, data-driven predictive model is needed to identify CMD risk in AMI patients undergoing PCI.

Purpose of the Study:

  • To develop and validate a predictive model for identifying coronary microcirculatory dysfunction (CMD) in patients with acute myocardial infarction (AMI) after emergency percutaneous coronary intervention (PCI).
  • To utilize readily available clinical variables for predicting comorbid CMD in this patient population.

Main Methods:

  • Prospective case-control study involving 77 patients with AMI who underwent PCI.
  • Least Absolute Shrinkage and Selection Operator (LASSO) analysis and multi-factor logistic regression to identify key predictors.
  • Cardiac magnetic resonance (CMR) imaging used for CMD diagnosis and model validation via bootstrap resampling (500 iterations).

Main Results:

  • Sex, neutrophil-to-lymphocyte ratio (NLR), Gensini score, and diabetes mellitus identified as independent predictors of CMD.
  • The predictive model achieved an Area Under the Curve (AUC) of 0.897 (95% CI: 0.827-0.958).
  • Calibration curves showed good agreement between model predictions and CMR findings; decision curve analysis confirmed clinical utility.

Conclusions:

  • A multivariate predictive model using accessible clinical variables effectively predicts comorbid CMD in AMI patients post-PCI.
  • This model aids in the early identification of high-risk patients requiring closer monitoring or intervention.
  • The findings support the integration of this predictive tool into clinical practice for improved patient management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Acute Coronary SyndromeI: Introduction01:30

Acute Coronary SyndromeI: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
3